Basiliximab Intravenous and Sandostatin LAR
Determining the interaction of Basiliximab Intravenous and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Sandostatin LAR Depot
- Basiliximab Intravenous-Sandostatin LAR Depot injection
- Basiliximab Intravenous-Sani-Supp
- Basiliximab Intravenous-Sani-Supp rectal
- Basiliximab Intravenous-Sansert
- Basiliximab Intravenous-Santyl
- Sandostatin LAR-Bavencio
- Sandostatin LAR-Baxdela
- Sandostatin LAR-Baxdela (Delafloxacin Injection)
- Sandostatin LAR-Baxdela (Delafloxacin Tablets)
- Sandostatin LAR-Baxdela Intravenous
- Sandostatin LAR-Baycadron